Vaccine Info

Recombivax HB Hepatitis B Vaccine

Description

Recombivax HB consists of each 1 mL contains 10 µg hepatitis B surface antigen

Indication

Recombivax HB is indicated for the prevention of infection caused by all known subtypes of hepatitis B virus. 

Dosage

Recombivax HB is administered as an intramuscular injection

Recombivax HB is approved for use in individuals of all ages.

Recombivax HB Dialysis Formulation is approved for use in adult predialysis and dialysis patients 18 years of age and older.

Infants, Children, Adolescents:         0–19 years of age   (Pediatric/adolescent formulation)5 mcg (0.5 mL)       3 doses at 0, 1, and 6 months

Adolescents:                             11 through 15 years of age       (Adult formulation)10 mcgc (1.0 mL)                  2 doses at 0 and 4–6 months

Adults:                                              ≥20 years of age           (Adult formulation)10 mcgc (1.0 mL)                       3 doses at  0, 1, and 6 months

Predialysis and Dialysis Patients:                                      (Dialysis formulation)40 mcg (1.0 mL)                        3 doses at 0, 1, and 6 months

Updated
September 30th, 2019